Annual Net Income
-$161.34 M
-$38.02 M-30.83%
December 31, 2023
Summary
- As of February 7, 2025, PLRX annual net profit is -$161.34 million, with the most recent change of -$38.02 million (-30.83%) on December 31, 2023.
- During the last 3 years, PLRX annual net income has fallen by -$119.80 million (-288.45%).
- PLRX annual net income is now -25468.30% below its all-time high of -$631.00 thousand, reached on December 31, 2019.
Performance
PLRX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$57.76 M
-$1.91 M-3.42%
September 30, 2024
Summary
- As of February 7, 2025, PLRX quarterly net profit is -$57.76 million, with the most recent change of -$1.91 million (-3.42%) on September 30, 2024.
- Over the past year, PLRX quarterly net income has dropped by -$1.91 million (-3.42%).
- PLRX quarterly net income is now -236.98% below its all-time high of $42.17 million, reached on December 31, 2019.
Performance
PLRX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$201.68 M
-$16.28 M-8.78%
September 30, 2024
Summary
- As of February 7, 2025, PLRX TTM net profit is -$201.68 million, with the most recent change of -$16.28 million (-8.78%) on September 30, 2024.
- Over the past year, PLRX TTM net income has dropped by -$16.28 million (-8.78%).
- PLRX TTM net income is now -925.85% below its all-time high of $24.42 million, reached on March 31, 2020.
Performance
PLRX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
PLRX Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -30.8% | -3.4% | -8.8% |
| 3 y3 years | -288.4% | -3.4% | -8.8% |
| 5 y5 years | -432.9% | -237.0% | -10000.0% |
PLRX Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -65.9% | at low | -135.5% | at low | -107.4% | at low |
| 5 y | 5-year | <-9999.0% | at low | -237.0% | at low | -925.9% | at low |
| alltime | all time | <-9999.0% | at low | -237.0% | at low | -925.9% | at low |
Pliant Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$57.76 M(+3.4%) | -$201.68 M(+8.8%) |
| Jun 2024 | - | -$55.85 M(+19.0%) | -$185.41 M(+8.6%) |
| Mar 2024 | - | -$46.95 M(+14.2%) | -$170.74 M(+5.8%) |
| Dec 2023 | -$161.34 M(+30.8%) | -$41.11 M(-0.9%) | -$161.34 M(+3.9%) |
| Sep 2023 | - | -$41.49 M(+0.7%) | -$155.29 M(+7.5%) |
| Jun 2023 | - | -$41.19 M(+9.7%) | -$144.41 M(+8.8%) |
| Mar 2023 | - | -$37.55 M(+7.1%) | -$132.77 M(+7.7%) |
| Dec 2022 | -$123.32 M(+26.8%) | -$35.06 M(+14.5%) | -$123.32 M(+9.3%) |
| Sep 2022 | - | -$30.61 M(+3.6%) | -$112.79 M(+3.3%) |
| Jun 2022 | - | -$29.55 M(+5.1%) | -$109.22 M(+6.6%) |
| Mar 2022 | - | -$28.10 M(+14.5%) | -$102.51 M(+5.4%) |
| Dec 2021 | -$97.26 M | -$24.53 M(-9.3%) | -$97.26 M(+6.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$27.05 M(+18.5%) | -$91.76 M(+12.9%) |
| Jun 2021 | - | -$22.83 M(-0.1%) | -$81.25 M(+7.7%) |
| Mar 2021 | - | -$22.86 M(+20.1%) | -$75.42 M(+81.6%) |
| Dec 2020 | -$41.53 M(+6482.1%) | -$19.03 M(+15.1%) | -$41.53 M(-311.2%) |
| Sep 2020 | - | -$16.53 M(-2.7%) | $19.66 M(-14.3%) |
| Jun 2020 | - | -$17.00 M(-254.1%) | $22.94 M(-6.1%) |
| Mar 2020 | - | $11.03 M(-73.8%) | $24.42 M(-3970.2%) |
| Dec 2019 | -$631.00 K(-97.9%) | $42.17 M(-418.1%) | -$631.00 K(-98.5%) |
| Sep 2019 | - | -$13.26 M(-14.6%) | -$42.80 M(+44.9%) |
| Jun 2019 | - | -$15.52 M(+10.7%) | -$29.55 M(+110.7%) |
| Mar 2019 | - | -$14.02 M | -$14.02 M |
| Dec 2018 | -$30.28 M | - | - |
FAQ
- What is Pliant Therapeutics annual net profit?
- What is the all time high annual net income for Pliant Therapeutics?
- What is Pliant Therapeutics annual net income year-on-year change?
- What is Pliant Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Pliant Therapeutics?
- What is Pliant Therapeutics quarterly net income year-on-year change?
- What is Pliant Therapeutics TTM net profit?
- What is the all time high TTM net income for Pliant Therapeutics?
- What is Pliant Therapeutics TTM net income year-on-year change?
What is Pliant Therapeutics annual net profit?
The current annual net income of PLRX is -$161.34 M
What is the all time high annual net income for Pliant Therapeutics?
Pliant Therapeutics all-time high annual net profit is -$631.00 K
What is Pliant Therapeutics annual net income year-on-year change?
Over the past year, PLRX annual net profit has changed by -$38.02 M (-30.83%)
What is Pliant Therapeutics quarterly net profit?
The current quarterly net income of PLRX is -$57.76 M
What is the all time high quarterly net income for Pliant Therapeutics?
Pliant Therapeutics all-time high quarterly net profit is $42.17 M
What is Pliant Therapeutics quarterly net income year-on-year change?
Over the past year, PLRX quarterly net profit has changed by -$1.91 M (-3.42%)
What is Pliant Therapeutics TTM net profit?
The current TTM net income of PLRX is -$201.68 M
What is the all time high TTM net income for Pliant Therapeutics?
Pliant Therapeutics all-time high TTM net profit is $24.42 M
What is Pliant Therapeutics TTM net income year-on-year change?
Over the past year, PLRX TTM net profit has changed by -$16.28 M (-8.78%)